home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

MYC Flicks The Switch On Liver Cancer

  October, 12 2004 8:20
your information resource in human molecular genetics
Hepatocellular carcinoma, a form of liver cancer, is generally unresponsive to treatment. A report published online by Nature, however, shows that tumorigenesis in mice can be reversed simply by switching off a gene. As Dean W. Felsher and colleagues report, inactivating the MYC oncogene prompts cancer cells to behave themselves, differentiating into hepatocytes (liver cells) and associated structures, rather than into the range of aberrant forms characteristic of tumours. Reactivation of the MYC oncogene, however, kicks the cells back to the dark side. These results show how oncogene inactivation may reverse tumorigenesis in the most clinically difficult cancers - more fundamentally, the inactivation of oncogenes uncovers the capacity of tumour cells to differentiate into normal cells and tissues, while retaining their latent potential to become cancerous.

Author contact:

Dean W Felsher (Stanford University, CA, USA)
Tel: +1 650 498 5269
E-mail: dfelsher@stanford.edu

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.